Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ligtenberg

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
International Journal of Cancer|November 21, 2019
Prediction of clinical benefit from androgen deprivation therapy in salivary duct carcinoma patientsWim van Boxtel, Gerald W Verhaegh, Ilse A van Engen-van Grunsven, et al.
European Journal of Human Genetics : EJHG|November 6, 2014
Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancerFadwa A Elsayed, C Marleen Kets, Dina Ruano, et al.
Human Genetics|January 13, 2006
MUTYH and the mismatch repair system: partners in crime?Renée C Niessen, Rolf H Sijmons, J Ou, et al.
Journal of Medical Genetics|February 7, 2014
Functional analysis of MSH2 unclassified variants found in suspected Lynch syndrome patients reveals pathogenicity due to attenuated mismatch repairEva A L Wielders, Jan Hettinger, Rob Dekker, et al.
Nature Genetics|November 14, 1997
BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patientsA Petrij-Bosch, T Peelen, M van Vliet, et al.
International Journal of Cancer|October 25, 2011
CDH1-related hereditary diffuse gastric cancer syndrome: clinical variations and implications for counselingIrma Kluijt, Ester J M Siemerink, Margreet G E M Ausems, et al.
British Journal of Cancer|April 3, 1999
Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2M J Ligtenberg, F B Hogervorst, H W Willems, et al.
Gastroenterology|November 7, 2007
DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's diseaseMarcus Renner, Gaby Bergmann, Inge Krebs, et al.
American Journal of Human Genetics|May 1, 1997
A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer familiesT Peelen, M van Vliet, A Petrij-Bosch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2018
High Yield of Pathogenic Germline Mutations Causative or Likely Causative of the Cancer Phenotype in Selected Children with CancerIllja J Diets, Esmé Waanders, Marjolijn J Ligtenberg, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
International Journal of Cancer|November 21, 2019
Prediction of clinical benefit from androgen deprivation therapy in salivary duct carcinoma patientsWim van Boxtel, Gerald W Verhaegh, Ilse A van Engen-van Grunsven, et al.
European Journal of Human Genetics : EJHG|November 6, 2014
Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancerFadwa A Elsayed, C Marleen Kets, Dina Ruano, et al.
Human Genetics|January 13, 2006
MUTYH and the mismatch repair system: partners in crime?Renée C Niessen, Rolf H Sijmons, J Ou, et al.
Journal of Medical Genetics|February 7, 2014
Functional analysis of MSH2 unclassified variants found in suspected Lynch syndrome patients reveals pathogenicity due to attenuated mismatch repairEva A L Wielders, Jan Hettinger, Rob Dekker, et al.
Nature Genetics|November 14, 1997
BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patientsA Petrij-Bosch, T Peelen, M van Vliet, et al.
International Journal of Cancer|October 25, 2011
CDH1-related hereditary diffuse gastric cancer syndrome: clinical variations and implications for counselingIrma Kluijt, Ester J M Siemerink, Margreet G E M Ausems, et al.
British Journal of Cancer|April 3, 1999
Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2M J Ligtenberg, F B Hogervorst, H W Willems, et al.
Gastroenterology|November 7, 2007
DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's diseaseMarcus Renner, Gaby Bergmann, Inge Krebs, et al.
American Journal of Human Genetics|May 1, 1997
A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer familiesT Peelen, M van Vliet, A Petrij-Bosch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2018
High Yield of Pathogenic Germline Mutations Causative or Likely Causative of the Cancer Phenotype in Selected Children with CancerIllja J Diets, Esmé Waanders, Marjolijn J Ligtenberg, et al.
Pageof 14